bf/NASDAQ:OMIC_icon.jpeg

COM:SINGULARGENOMICS

Singular Genomics

  • Stock

USD

Last Close

21.40

22/11 21:00

Market Cap

19.05M

Beta: -

Volume Today

10.54K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.51M
-
10.62M
605.15%
9.11M
14.18%
average payables
494K
-
1.39M
180.87%
2.72M
96.29%
1.55M
43.11%
average receivables
525K
-
981.50K
86.95%
456.50K
53.49%
book value per share
-0.50
-
-0.74
48.47%
7.15
1,062.12%
3.66
48.82%
capex per share
-0.02
-
-0.02
22.83%
-0.10
420.06%
-0.08
18.17%
capex to depreciation
-2.29
-
-2.16
5.52%
-4.29
98.79%
-1.00
76.75%
capex to operating cash flow
0.07
-
0.06
20.95%
0.09
69.57%
0.07
26.50%
capex to revenue
-7.87
-
cash per share
0.94
-
0.39
58.51%
7.21
1,759.36%
3.44
52.35%
days of inventory on hand
8.43K
-
days payables outstanding
1.43K
-
days sales outstanding
435.61
-
debt to assets
0.05
-
0.31
518.26%
0.03
90.96%
0.18
544.27%
debt to equity
-0.10
-
-0.18
87.74%
0.03
116.17%
0.23
667.26%
dividend yield
0.01
-
earnings yield
-0.01
-
-0.02
65.37%
-0.18
1,032.60%
-0.62
239.30%
enterprise value
1.27B
-
1.78B
40.61%
352.44M
80.22%
127.59M
63.80%
enterprise value over ebitda
-106.01
-
-67.53
36.29%
-5.82
91.38%
-1.42
75.68%
ev to operating cash flow
-111.20
-
-71.65
35.56%
-6.82
90.49%
-1.46
78.51%
ev to sales
166.78
-
free cash flow per share
-0.25
-
-0.38
53.23%
-1.20
217.91%
-1.31
8.80%
free cash flow yield
-0.01
-
-0.01
53.23%
-0.10
607.33%
-0.65
525.73%
graham net net
-0.54
-
-0.79
47.02%
6.85
961.78%
2.62
61.68%
graham number
1.68
-
2.63
56.69%
18.39
599.84%
10.11
45.05%
income quality
0.92
-
0.89
3.77%
0.52
41.19%
0.96
83.09%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-751.18
-
-38.35
94.89%
-72.43
88.88%
-122.53
69.16%
interest debt per share
0.05
-
0.15
197.92%
0.23
56.84%
0.84
266.47%
inventory turnover
0.04
-
invested capital
-0.10
-
-0.18
87.74%
0.03
116.17%
0.23
667.26%
market cap
1.27B
-
1.78B
40.44%
543.59M
69.54%
143.01M
73.69%
net current asset value
-26.44M
-
-54.49M
106.06%
328.29M
702.51%
200.78M
38.84%
net debt to ebitda
0.26
-
0.09
66.49%
3.16
3,533.40%
0.17
94.58%
net income per share
-0.25
-
-0.41
65.37%
-2.10
409.05%
-1.24
41.00%
operating cash flow per share
-0.23
-
-0.36
55.37%
-1.10
206.70%
-1.22
11.34%
payables turnover
0.25
-
receivables turnover
0.84
-
research and ddevelopement to revenue
60.39
-
return on tangible assets
-0.26
-
-0.94
266.82%
-0.28
70.41%
-0.27
3.21%
revenue per share
0.01
-
roe
0.50
-
0.56
11.39%
-0.29
152.91%
-0.34
15.27%
roic
0.57
-
0.67
16.95%
-0.18
126.46%
-0.25
39.21%
sales general and administrative to revenue
shareholders equity per share
-0.50
-
-0.74
48.47%
7.15
1,062.12%
3.66
48.82%
stock based compensation to revenue
17.87
-
tangible asset value
-24.73M
-
-51.55M
108.51%
336.17M
752.07%
260.32M
22.56%
tangible book value per share
-0.50
-
-0.74
48.47%
7.15
1,062.12%
3.66
48.82%
working capital
45.34M
-
23.88M
47.33%
341.02M
1,327.98%
254.31M
25.42%

All numbers in USD (except ratios and percentages)